|
|
|
Volumn 267, Issue 7171, 2001, Pages 600-612
|
|
(14) Parkinson's disease
a a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMANTADINE;
ANTIEMETIC AGENT;
ANTIPARKINSON AGENT;
APOMORPHINE;
BROMOCRIPTINE;
CABERGOLINE;
CALCIUM CHANNEL BLOCKING AGENT;
CAPTOPRIL;
CATECHOL METHYLTRANSFERASE INHIBITOR;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CINNARIZINE;
CLOZAPINE;
DECARBOXYLASE INHIBITOR;
DOPAMINE RECEPTOR STIMULATING AGENT;
ENTACAPONE;
FLUNARIZINE;
LEVODOPA;
LISURIDE;
METOCLOPRAMIDE;
NAPROXEN;
OLANZAPINE;
PERGOLIDE;
PRAMIPEXOLE;
PROCHLORPERAZINE;
PROPANTHELINE BROMIDE;
QUETIAPINE;
RIVASTIGMINE;
ROPINIROLE;
SELEGILINE;
BRADYKINESIA;
CLINICAL FEATURE;
CONTROLLED STUDY;
DEMENTIA;
DEPRESSION;
DISEASE EXACERBATION;
DRUG INDICATION;
DRUG MECHANISM;
DYSKINESIA;
HALLUCINATION;
HUMAN;
INDIVIDUALIZATION;
MAINTENANCE THERAPY;
NOTE;
PALLIATIVE THERAPY;
PARKINSON DISEASE;
PATIENT CARE;
PREVALENCE;
PSYCHOSIS;
PUBLIC HEALTH;
QUALITY OF LIFE;
RIGIDITY;
TREATMENT PLANNING;
TREMOR;
|
|
EID: 0035960339
PISSN: 00316873
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (10)
|
|
References (0)
|